Skip to main content
Erschienen in: Child's Nervous System 10/2019

05.08.2019 | Special Annual Issue

Chiari malformation type I: what information from the genetics?

verfasst von: Valeria Capra, Michele Iacomino, Andrea Accogli, Marco Pavanello, Federico Zara, Armando Cama, Patrizia De Marco

Erschienen in: Child's Nervous System | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Chiari malformation type I (CMI), a rare disorder of the craniocerebral junction with an estimated incidence of 1 in 1280, is characterized by the downward herniation of the cerebellar tonsils of at least 5 mm through the foramen magnum, resulting in significant neurologic morbidity. Classical CMI is thought to be caused by an underdeveloped occipital bone, resulting in a posterior cranial fossa which is too small to accommodate the normal-sized cerebellum. In this review, we dissect the lines of evidence supporting a genetic contribution for this disorder.

Methods

We present the results of two types of approaches: animal models and human studies encompassing different study designs such as whole genome linkage analysis, case-control association studies, and expression studies. The update of the literature also includes the most recent findings emerged by whole exome sequencing strategy.

Results

Despite evidence for a genetic component, no major genes have been identified and the genetics of CMI is still very much unknown. One major challenge is the variability of clinical presentation within CMI patient population that reflects an underlying genetic heterogeneity.

Conclusions

The identification of the genes that contribute to the etiology of CMI will provide an important step to the understanding of the underlying pathology. The finding of a predisposing gene may lead to the development of simple and accurate diagnostic tests for better prognosis, counseling, and clinical management of patients and their relatives.
Literatur
1.
Zurück zum Zitat Barkovich AJ, Wippold FJ, Sherman JL, Citrin CM (1986) Significance of cerebellar tonsillar position on MR. AJNR Am J Neuroradiol 7:795–799PubMedPubMedCentral Barkovich AJ, Wippold FJ, Sherman JL, Citrin CM (1986) Significance of cerebellar tonsillar position on MR. AJNR Am J Neuroradiol 7:795–799PubMedPubMedCentral
2.
Zurück zum Zitat Mueller DM, Oro’ JJ (2004) Prospective analysis of presenting symptoms among 265 patients with radiographic evidence of Chiari malformation type I with or without syringomyelia. J Am Acad Nurse Pract 16:134–138CrossRefPubMed Mueller DM, Oro’ JJ (2004) Prospective analysis of presenting symptoms among 265 patients with radiographic evidence of Chiari malformation type I with or without syringomyelia. J Am Acad Nurse Pract 16:134–138CrossRefPubMed
3.
Zurück zum Zitat Elster AD, Chen MY (1992) Chiari I malformations: clinical and radiologic reappraisal. Radiology 183(2):347–353CrossRefPubMed Elster AD, Chen MY (1992) Chiari I malformations: clinical and radiologic reappraisal. Radiology 183(2):347–353CrossRefPubMed
4.
Zurück zum Zitat Meadows J, Kraut M, Guarnieri M, Haroun RI, Carson BS (2000) Asymptomatic Chiari type I malformations identified on magnetic resonance imaging. J Neurosurg 92(6):920–926CrossRefPubMed Meadows J, Kraut M, Guarnieri M, Haroun RI, Carson BS (2000) Asymptomatic Chiari type I malformations identified on magnetic resonance imaging. J Neurosurg 92(6):920–926CrossRefPubMed
5.
Zurück zum Zitat Milhorat TH, Chou MW, Trinidad EM, Kula RW, Mandell M, Wolpert C, Speer MC (1999) Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients. Neurosurgery 44:1005–1017CrossRefPubMed Milhorat TH, Chou MW, Trinidad EM, Kula RW, Mandell M, Wolpert C, Speer MC (1999) Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients. Neurosurgery 44:1005–1017CrossRefPubMed
6.
Zurück zum Zitat Fernández AA, Guerrero AI, Martínez MI, Vázquez ME, Fernández JB, Chesa i, Octavio E et al (2009) Malformations of the craniocervical junction (Chiari type I and syringomyelia: classification, diagnosis and treatment). BMC Musculoskelet Disord 10(Suppl 1):S1CrossRefPubMed Fernández AA, Guerrero AI, Martínez MI, Vázquez ME, Fernández JB, Chesa i, Octavio E et al (2009) Malformations of the craniocervical junction (Chiari type I and syringomyelia: classification, diagnosis and treatment). BMC Musculoskelet Disord 10(Suppl 1):S1CrossRefPubMed
7.
Zurück zum Zitat Greenlee JD, Donovan KA, Hasan DM, Menezes AH (2002) Chiari I malformation in the very young child: the spectrum of presentations and experience in 31 children under age 6 years. Pediatrics 110:1212–1219CrossRefPubMed Greenlee JD, Donovan KA, Hasan DM, Menezes AH (2002) Chiari I malformation in the very young child: the spectrum of presentations and experience in 31 children under age 6 years. Pediatrics 110:1212–1219CrossRefPubMed
8.
Zurück zum Zitat Martinot A, Hue V, Leclerc F, Vallee L, Closset M, Pruvo JP (1993) Sudden death revealing Chiari type 1 malformation in two children. Intensive Care Med 19:73–74CrossRefPubMed Martinot A, Hue V, Leclerc F, Vallee L, Closset M, Pruvo JP (1993) Sudden death revealing Chiari type 1 malformation in two children. Intensive Care Med 19:73–74CrossRefPubMed
9.
Zurück zum Zitat Milhorat TH, Nishikawa M, Kula RW et al (2010) Mechanisms of cerebellar tonsil herniation in patients with Chiari malformations as guide to clinical management (1010). Acta Neurochir 152:1117–1127CrossRefPubMed Milhorat TH, Nishikawa M, Kula RW et al (2010) Mechanisms of cerebellar tonsil herniation in patients with Chiari malformations as guide to clinical management (1010). Acta Neurochir 152:1117–1127CrossRefPubMed
10.
Zurück zum Zitat Tubbs RS, Beckman J, Naftel RP, Chern JJ, Wellons JC, Rozzelle CJ, Blount JP, Oakes WJ (2011) Institutional experience with 500 cases of surgically treated pediatric Chiari malformation type I. J Neurosurg Pediatr 7:248–256CrossRefPubMed Tubbs RS, Beckman J, Naftel RP, Chern JJ, Wellons JC, Rozzelle CJ, Blount JP, Oakes WJ (2011) Institutional experience with 500 cases of surgically treated pediatric Chiari malformation type I. J Neurosurg Pediatr 7:248–256CrossRefPubMed
11.
Zurück zum Zitat Small JA, Sheridan PH (1996) Research priorities for syringomyelia: a National Institute of Neurological Disorders and Stroke workshop summary. Neurology 46:577–582CrossRefPubMed Small JA, Sheridan PH (1996) Research priorities for syringomyelia: a National Institute of Neurological Disorders and Stroke workshop summary. Neurology 46:577–582CrossRefPubMed
12.
Zurück zum Zitat Speer MC, Enterline DS, Mehltretter L, Hammock P, Joseph J, Dickerson M et al (2003) Chiari type I malformation with or without syringomyelia: prevalence and genetics. J Genet Couns 12:297–311CrossRefPubMed Speer MC, Enterline DS, Mehltretter L, Hammock P, Joseph J, Dickerson M et al (2003) Chiari type I malformation with or without syringomyelia: prevalence and genetics. J Genet Couns 12:297–311CrossRefPubMed
13.
Zurück zum Zitat Stovner LJ, Cappelen J, Nilsen G, Sjaastad O (1992) The Chiari type I malformation in two monozygotic twins and first-degree relatives. Ann Neurol 31:220–222CrossRefPubMed Stovner LJ, Cappelen J, Nilsen G, Sjaastad O (1992) The Chiari type I malformation in two monozygotic twins and first-degree relatives. Ann Neurol 31:220–222CrossRefPubMed
14.
Zurück zum Zitat Cavender RK, Schmidt JH (1995) Tonsillar ectopia and Chiari malformations: monozygotic triplets. Case report. J Neurosurg 82:497–500CrossRefPubMed Cavender RK, Schmidt JH (1995) Tonsillar ectopia and Chiari malformations: monozygotic triplets. Case report. J Neurosurg 82:497–500CrossRefPubMed
15.
Zurück zum Zitat Turgut M (2001) Chiari type I malformation in two monozygotic twins. Brit J Neurosurg 15:279–280CrossRef Turgut M (2001) Chiari type I malformation in two monozygotic twins. Brit J Neurosurg 15:279–280CrossRef
16.
Zurück zum Zitat Speer MC, George TM, Enterline DS, Franklin A, Wolpert CM, Milhorat TH (2000) A genetic hypothesis for Chiari I malformation with or without syringomyelia. Neurosurg Focus 8:E12CrossRefPubMed Speer MC, George TM, Enterline DS, Franklin A, Wolpert CM, Milhorat TH (2000) A genetic hypothesis for Chiari I malformation with or without syringomyelia. Neurosurg Focus 8:E12CrossRefPubMed
17.
Zurück zum Zitat Afifi AK, Dolan KD, Van Gilder JC, Fincham RW (1988) Ventriculomegaly in neurofibromatosis-1. Association with Chiari type I malformation. Neurofibromatosis 1:299–305PubMed Afifi AK, Dolan KD, Van Gilder JC, Fincham RW (1988) Ventriculomegaly in neurofibromatosis-1. Association with Chiari type I malformation. Neurofibromatosis 1:299–305PubMed
18.
Zurück zum Zitat Cohen MM Jr, Kreiborg S (1992) Birth prevalence studies of the Crouzon syndrome comparison of direct and indirect methods. Clin Genet 41:12–15CrossRefPubMed Cohen MM Jr, Kreiborg S (1992) Birth prevalence studies of the Crouzon syndrome comparison of direct and indirect methods. Clin Genet 41:12–15CrossRefPubMed
19.
Zurück zum Zitat Dooley J, Vaughan D, Riding M, Camfield P (1993) The association of Chiari type I malformation and neurofibromatosis type I. Clin Pediatr (Phila) 32:189–190CrossRef Dooley J, Vaughan D, Riding M, Camfield P (1993) The association of Chiari type I malformation and neurofibromatosis type I. Clin Pediatr (Phila) 32:189–190CrossRef
20.
Zurück zum Zitat Pober BR, Filiano JJ (1995) Association of Chiari I malformation and Williams syndrome. Pediatr Neurol 12:84–88CrossRefPubMed Pober BR, Filiano JJ (1995) Association of Chiari I malformation and Williams syndrome. Pediatr Neurol 12:84–88CrossRefPubMed
21.
Zurück zum Zitat Fujisawa H, Hasegawa M, Kida S, Yamashita J (2002) A novel fibroblast growth factor receptor 2 mutation in Crouzon syndrome associated with Chiari type I malformation and syringomyelia. J Neurosurg 97:396–400CrossRefPubMed Fujisawa H, Hasegawa M, Kida S, Yamashita J (2002) A novel fibroblast growth factor receptor 2 mutation in Crouzon syndrome associated with Chiari type I malformation and syringomyelia. J Neurosurg 97:396–400CrossRefPubMed
22.
Zurück zum Zitat Caldemeyer KS, Boaz JC, Wappner RS, Moran CC, Smith RR, Quets JP (1995) Chiari 1 malformation: association with hypophosphatemic rickets and MR imaging appearance. Radiology 195:733–738CrossRefPubMed Caldemeyer KS, Boaz JC, Wappner RS, Moran CC, Smith RR, Quets JP (1995) Chiari 1 malformation: association with hypophosphatemic rickets and MR imaging appearance. Radiology 195:733–738CrossRefPubMed
23.
Zurück zum Zitat Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, Puffenberger EG, Hamosh A, Nanthakumar EJ, Curristin SM, Stetten G, Meyers DA, Francomano CA (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337–339CrossRefPubMed Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, Puffenberger EG, Hamosh A, Nanthakumar EJ, Curristin SM, Stetten G, Meyers DA, Francomano CA (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337–339CrossRefPubMed
24.
Zurück zum Zitat Dietz HC, Sood S, Mcintosh J (1995) The phenotypic continuum associated with Fbn1 mutations includes the Shprintzen-Goldberg syndrome. Am J Hum Genet 57:1214 Dietz HC, Sood S, Mcintosh J (1995) The phenotypic continuum associated with Fbn1 mutations includes the Shprintzen-Goldberg syndrome. Am J Hum Genet 57:1214
25.
Zurück zum Zitat Iglesias-Osma C, Gomez Sanchez JC, Suquia MB, Querol PR, de Portugal AJ (1997) Paget’s disease of bone and basilar impression associated with an Arnold-Chiari type-1 malformation. An Med Interna 14:519–522PubMed Iglesias-Osma C, Gomez Sanchez JC, Suquia MB, Querol PR, de Portugal AJ (1997) Paget’s disease of bone and basilar impression associated with an Arnold-Chiari type-1 malformation. An Med Interna 14:519–522PubMed
26.
Zurück zum Zitat Milhorat TH, Bolognese PA, Nishikawa M, McDonnell NB, Francomano CA (2007) Syndrome of occipitoatlantoaxial hypermobility, cranial settling, and chiari malformation type I in patients with hereditary disorders of connective tissue. J Neurosurg Spine 7(6):601–609CrossRefPubMed Milhorat TH, Bolognese PA, Nishikawa M, McDonnell NB, Francomano CA (2007) Syndrome of occipitoatlantoaxial hypermobility, cranial settling, and chiari malformation type I in patients with hereditary disorders of connective tissue. J Neurosurg Spine 7(6):601–609CrossRefPubMed
27.
Zurück zum Zitat Hamilton J, Blaser S, Daneman D (1998) MR imaging in idiopathic growth hormone deficiency. AJNR Am J Neuroradiol 19:1609–1615PubMedPubMedCentral Hamilton J, Blaser S, Daneman D (1998) MR imaging in idiopathic growth hormone deficiency. AJNR Am J Neuroradiol 19:1609–1615PubMedPubMedCentral
28.
Zurück zum Zitat Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M (1994) Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 125:29–35CrossRefPubMed Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M (1994) Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 125:29–35CrossRefPubMed
29.
Zurück zum Zitat Kuether TA, Piatt JH (1998) Chiari malformation associated with vitamin D resistant rickets case report. Neurosurgery 42:1168–1171CrossRefPubMed Kuether TA, Piatt JH (1998) Chiari malformation associated with vitamin D resistant rickets case report. Neurosurgery 42:1168–1171CrossRefPubMed
30.
Zurück zum Zitat Marin-Padilla M, Marin-Padilla TM (1981) Morphogenesis of experimentally induced Arnold–Chiari malformation. J Neurol Sci 50:29–55CrossRefPubMed Marin-Padilla M, Marin-Padilla TM (1981) Morphogenesis of experimentally induced Arnold–Chiari malformation. J Neurol Sci 50:29–55CrossRefPubMed
31.
Zurück zum Zitat Noudel R, Jovenin N, Eap C, Scherpereel B, Pierot L, Rousseaux P (2009) Incidence of basioccipital hypoplasia in Chiari malformation type I: comparative morphometric study of the posterior cranial fossa. Clinical article. J Neurosurg 111(5):1046–1052CrossRefPubMed Noudel R, Jovenin N, Eap C, Scherpereel B, Pierot L, Rousseaux P (2009) Incidence of basioccipital hypoplasia in Chiari malformation type I: comparative morphometric study of the posterior cranial fossa. Clinical article. J Neurosurg 111(5):1046–1052CrossRefPubMed
32.
Zurück zum Zitat Bernard S, Loukas M, Rizk E, Oskouian RJ, Delashaw J, Tubbs RS (2015) The human occipital bone: review and update on its embryology and molecular development. Childs Nerv Syst 31(12):2217–2223CrossRefPubMed Bernard S, Loukas M, Rizk E, Oskouian RJ, Delashaw J, Tubbs RS (2015) The human occipital bone: review and update on its embryology and molecular development. Childs Nerv Syst 31(12):2217–2223CrossRefPubMed
33.
Zurück zum Zitat Lin GL, Hankenson KD (2011) Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 112(12):3491–3501CrossRefPubMedPubMedCentral Lin GL, Hankenson KD (2011) Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 112(12):3491–3501CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Pownall ME, Isaacs HV (2010) FGF signalling in vertebrate development. Morgan & Claypool Life Sciences, San RafaelCrossRef Pownall ME, Isaacs HV (2010) FGF signalling in vertebrate development. Morgan & Claypool Life Sciences, San RafaelCrossRef
37.
Zurück zum Zitat Nie X, Luukko K, Kettunen P (2006) FGF signalling in craniofacial development and developmental disorders. Oral Dis 12:102–111CrossRefPubMed Nie X, Luukko K, Kettunen P (2006) FGF signalling in craniofacial development and developmental disorders. Oral Dis 12:102–111CrossRefPubMed
38.
Zurück zum Zitat Liu C-F, Samsa WE, Zhou G, Lefebvre V (2017) Transcriptional control of chondrocyte specification and differentiation. Semin Cell Dev Biol 62:34–49CrossRefPubMed Liu C-F, Samsa WE, Zhou G, Lefebvre V (2017) Transcriptional control of chondrocyte specification and differentiation. Semin Cell Dev Biol 62:34–49CrossRefPubMed
39.
Zurück zum Zitat Ziros PG, Basdra EK, Papavassiliou AG (2008) Runx2: of bone and stretch. Int J Biochem Cell Biol 40(9):1659–16663CrossRefPubMed Ziros PG, Basdra EK, Papavassiliou AG (2008) Runx2: of bone and stretch. Int J Biochem Cell Biol 40(9):1659–16663CrossRefPubMed
40.
Zurück zum Zitat Rusbridge C, Knowler SP (2003) Hereditary aspects of occipital bone hypoplasia and syringomyelia (Chiari type I malformation) in cavalier King Charles spaniels. Vet Record 153:107–112CrossRefPubMed Rusbridge C, Knowler SP (2003) Hereditary aspects of occipital bone hypoplasia and syringomyelia (Chiari type I malformation) in cavalier King Charles spaniels. Vet Record 153:107–112CrossRefPubMed
41.
Zurück zum Zitat Rusbridge C, Knowler SP (2004) Inheritance of occipital bone hypoplasia (Chiari type I malformation) in Cavalier King Charles spaniels. J Vet Int Med 18:673–678CrossRef Rusbridge C, Knowler SP (2004) Inheritance of occipital bone hypoplasia (Chiari type I malformation) in Cavalier King Charles spaniels. J Vet Int Med 18:673–678CrossRef
42.
Zurück zum Zitat Lemay P, Knowler SP, Bouasker S, Nédélec Y, Platt S, Freeman C, Child G, Barreiro LB, Rouleau GA, Rusbridge C, Kibar Z (2014) Quantitative trait loci (QTL) study identifies novel genomic regions associated to Chiari-like malformation in Griffon Bruxellois dogs. PLoS One 9(4):e89816CrossRefPubMedPubMedCentral Lemay P, Knowler SP, Bouasker S, Nédélec Y, Platt S, Freeman C, Child G, Barreiro LB, Rouleau GA, Rusbridge C, Kibar Z (2014) Quantitative trait loci (QTL) study identifies novel genomic regions associated to Chiari-like malformation in Griffon Bruxellois dogs. PLoS One 9(4):e89816CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Ancot F, Lemay P, Knowler SP, Kennedy K, Griffiths S, Cherubini GB, Sykes J, Mandigers PJJ, Rouleau GA, Rusbridge C, Kibar Z (2018) A genome-wide association study identifies candidate loci associated to syringomyelia secondary to Chiari-like malformation in Cavalier King Charles Spaniels. BMC Genet 19(1):16CrossRefPubMedPubMedCentral Ancot F, Lemay P, Knowler SP, Kennedy K, Griffiths S, Cherubini GB, Sykes J, Mandigers PJJ, Rouleau GA, Rusbridge C, Kibar Z (2018) A genome-wide association study identifies candidate loci associated to syringomyelia secondary to Chiari-like malformation in Cavalier King Charles Spaniels. BMC Genet 19(1):16CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Solis-Moruno M, de Manuel M, Hernandez-Rodriguez J, Fontsere C, Gomara-Castaño A, Valsera-Naranjo C, Crailsheim D, Navarro A (2017) Potential damaging mutation in LRP5 from genome sequencing of the first reported chimpanzee with the Chiari malformation. Sci Rep 7(1):15224CrossRefPubMedPubMedCentral Solis-Moruno M, de Manuel M, Hernandez-Rodriguez J, Fontsere C, Gomara-Castaño A, Valsera-Naranjo C, Crailsheim D, Navarro A (2017) Potential damaging mutation in LRP5 from genome sequencing of the first reported chimpanzee with the Chiari malformation. Sci Rep 7(1):15224CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Markunas CA, Soldano K, Dunlap K, Cope H, Assimwe E, Stajich J, Enterline D, Grant G, Fuchs H, Gregory SG, Ashley-Koch AE (2013) Stratified whole genome linkage analysis of Chiari type I malformation implicates known Klippel-Feil syndrome genes as putative disease candidates. PLoS One 8:e615CrossRef Markunas CA, Soldano K, Dunlap K, Cope H, Assimwe E, Stajich J, Enterline D, Grant G, Fuchs H, Gregory SG, Ashley-Koch AE (2013) Stratified whole genome linkage analysis of Chiari type I malformation implicates known Klippel-Feil syndrome genes as putative disease candidates. PLoS One 8:e615CrossRef
46.
Zurück zum Zitat Boyles AL, Enterline DS, Hammock PH, Siegel DG, Slifer SH, Mehltretter L et al (2006) Phenotypic definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15. Am J Med Genet A 140:2776–2785CrossRefPubMed Boyles AL, Enterline DS, Hammock PH, Siegel DG, Slifer SH, Mehltretter L et al (2006) Phenotypic definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15. Am J Med Genet A 140:2776–2785CrossRefPubMed
47.
Zurück zum Zitat Urbizu A, Toma C, Poca MA, Sahuquillo J, Cuenca-Leo E, Cormand B, Macaya A (2013) Chiari malformation type I: a case-control association study of 58 developmental genes. PLoS One 8(2):e5724CrossRef Urbizu A, Toma C, Poca MA, Sahuquillo J, Cuenca-Leo E, Cormand B, Macaya A (2013) Chiari malformation type I: a case-control association study of 58 developmental genes. PLoS One 8(2):e5724CrossRef
48.
Zurück zum Zitat Markunas CA, Enterline DS, Dunlap K, Soldano K, Cope H, Stajich J, Grant G, Fuchs H, Gregory SG, Ashley-Koch AE (2014) Genetic evaluation and application of posterior cranial fossa traits as endophenotypes for Chiari type I malformation. Ann Hum Genet 78(1):1–12CrossRefPubMed Markunas CA, Enterline DS, Dunlap K, Soldano K, Cope H, Stajich J, Grant G, Fuchs H, Gregory SG, Ashley-Koch AE (2014) Genetic evaluation and application of posterior cranial fossa traits as endophenotypes for Chiari type I malformation. Ann Hum Genet 78(1):1–12CrossRefPubMed
49.
Zurück zum Zitat Lock EF, Soldano KL, Garrett ME, Cope H, Markunas CA, Fuchs H, Grant G, Dunson DB, Gregory SG, Ashley-Koch AE (2015) Joint eQTL assessment of whole blood and dura mater tissue from individuals with Chiari type I malformation. BMC Genomics 16:11CrossRefPubMedPubMedCentral Lock EF, Soldano KL, Garrett ME, Cope H, Markunas CA, Fuchs H, Grant G, Dunson DB, Gregory SG, Ashley-Koch AE (2015) Joint eQTL assessment of whole blood and dura mater tissue from individuals with Chiari type I malformation. BMC Genomics 16:11CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Merello E., Tattini L, Magi A, Accogli A, Piatelli GL, Pavanello M, Tortora D, Cama A, Kibar Z, Capra V, De Marco P (2017) Exome sequencing of two Italian pedigrees with non-isolated Chiari malformation type I reveals candidate genes for cranio-facial development. Eur J Hum Genet 25:952–958 Merello E., Tattini L, Magi A, Accogli A, Piatelli GL, Pavanello M, Tortora D, Cama A, Kibar Z, Capra V, De Marco P (2017) Exome sequencing of two Italian pedigrees with non-isolated Chiari malformation type I reveals candidate genes for cranio-facial development. Eur J Hum Genet 25:952–958
51.
Zurück zum Zitat Bamshad MJ, Ng SB, Shendure J (2011) Exome sequencing as a tool for Mendeleian disease gene discovery. Nature Review Genetics 12:745–755 Bamshad MJ, Ng SB, Shendure J (2011) Exome sequencing as a tool for Mendeleian disease gene discovery. Nature Review Genetics 12:745–755
52.
Zurück zum Zitat Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, Shaffer T, Wong M, Bhattacharjee A, Elcher EE, Bamshad M, Nickerson DA, Shendure J (2009) Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461:272–276 Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, Shaffer T, Wong M, Bhattacharjee A, Elcher EE, Bamshad M, Nickerson DA, Shendure J (2009) Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461:272–276
53.
Zurück zum Zitat Nilda A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, Sugano S, Akiyama (2004) DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 23:8520–8526 Nilda A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, Sugano S, Akiyama (2004) DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 23:8520–8526
54.
Zurück zum Zitat Mukhopadhyay M, Shtrom S, Rodriguez-Esteban C, Chen L, Tsukui T, Gomer L, et al (2001) Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Developmental Cell 1:423–434 Mukhopadhyay M, Shtrom S, Rodriguez-Esteban C, Chen L, Tsukui T, Gomer L, et al (2001) Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Developmental Cell 1:423–434
55.
Zurück zum Zitat Choi HY, Dieckmann M, Herz J, Niemeier A (2009) Lrp4, a novel receptor for Dickkopf 1 and Sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. Plos ONE 4(11):e7930 Choi HY, Dieckmann M, Herz J, Niemeier A (2009) Lrp4, a novel receptor for Dickkopf 1 and Sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. Plos ONE 4(11):e7930
56.
Zurück zum Zitat Johnson EB, Hammer RE, Herz J (2005) Abnornal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. Hum Mol Genet 14:3523–3538 Johnson EB, Hammer RE, Herz J (2005) Abnornal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. Hum Mol Genet 14:3523–3538
Metadaten
Titel
Chiari malformation type I: what information from the genetics?
verfasst von
Valeria Capra
Michele Iacomino
Andrea Accogli
Marco Pavanello
Federico Zara
Armando Cama
Patrizia De Marco
Publikationsdatum
05.08.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 10/2019
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-019-04322-w

Weitere Artikel der Ausgabe 10/2019

Child's Nervous System 10/2019 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.